CSL bets $1b on new heart and transplant drugs
SYDNEY: Blood products giant CSL plans to spend $1 billion proving up potential blockbuster drugs
SYDNEY: Blood products giant CSL plans to spend $1 billion proving up potential blockbuster drugs